Scienture Holdings Divests Legacy Subsidiaries for $5 Million, Focuses on Branded and Specialty Pharma Segment

Scienture Holdings has divested its legacy subsidiaries, Integra Pharma Solutions, Bonum Health, and Softell, to Tollo Health for $5 million. This strategic move is part of the company's plan to streamline operations, optimize its portfolio, and accelerate growth in the Branded and Specialty Pharma markets. The proceeds from the divestment will be used to facilitate high-growth commercial and strategic product development activities at Scienture, LLC. The company believes the divestitures will increase operational efficiency, realize synergies, and allow for dedicated focus on its high-value business.